A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

LESSONS LEARNED: A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medicine formulation can work with Western cancer chemotherapeutic agents to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Changou, Chun A., Shiah, Her‐Shyong, Chen, Li‐Tzong, Liu, Servina, Luh, Frank, Liu, Shwu‐Huey, Cheng, Yung‐Chi, Yen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930412/
https://www.ncbi.nlm.nih.gov/pubmed/33140457
http://dx.doi.org/10.1002/onco.13582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930412/
https://www.ncbi.nlm.nih.gov/pubmed/33140457
http://dx.doi.org/10.1002/onco.13582

Ejemplares similares